Heidelberg Pharma AG (ETR:HPHA)

Heidelberg Pharma AG Statistics

Total Valuation

ETR:HPHA has a market cap or net worth of EUR 127.72 million. The enterprise value is 118.54 million.

Market Cap	127.72M
Enterprise Value	118.54M

Important Dates

The next confirmed earnings date is Wednesday, July 15, 2026.

Earnings Date	Jul 15, 2026
Ex-Dividend Date	n/a

Share Statistics

ETR:HPHA has 46.78 million shares outstanding. The number of shares has increased by 0.72% in one year.

Current Share Class	46.78M
Shares Outstanding	46.78M
Shares Change (YoY)	+0.72%
Shares Change (QoQ)	+2.57%
Owned by Insiders (%)	2.31%
Owned by Institutions (%)	0.73%
Float	9.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	48.16
PB Ratio	-8.43
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.92
EV / Sales	44.70
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.04

Financial Position

The company has a current ratio of 2.40

Current Ratio	2.40
Quick Ratio	1.29
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.00
Interest Coverage	-11,532.04

Financial Efficiency

Return on equity (ROE) is -820.00% and return on invested capital (ROIC) is -581.79%.

Return on Equity (ROE)	-820.00%
Return on Assets (ROA)	-70.55%
Return on Invested Capital (ROIC)	-581.79%
Return on Capital Employed (ROCE)	-216.93%
Weighted Average Cost of Capital (WACC)	8.30%
Revenue Per Employee	23,891
Profits Per Employee	-365,938
Employee Count	114
Asset Turnover	0.06
Inventory Turnover	0.05

Taxes

In the past 12 months, ETR:HPHA has paid 1.05 million in taxes.

Income Tax	1.05M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -11.94% in the last 52 weeks. The beta is 0.74, so ETR:HPHA's price volatility has been lower than the market average.

Beta (5Y)	0.74
52-Week Price Change	-11.94%
50-Day Moving Average	2.90
200-Day Moving Average	3.17
Relative Strength Index (RSI)	39.32
Average Volume (20 Days)	3,100

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ETR:HPHA had revenue of EUR 2.65 million and -40.62 million in losses. Loss per share was -0.87.

Revenue	2.65M
Gross Profit	2.05M
Operating Income	-47.18M
Pretax Income	-39.57M
Net Income	-40.62M
EBITDA	-46.62M
EBIT	-47.18M
Loss Per Share	-0.87

Balance Sheet

The company has 9.26 million in cash and 77,404 in debt, with a net cash position of 9.18 million or 0.20 per share.

Cash & Cash Equivalents	9.26M
Total Debt	77,404
Net Cash	9.18M
Net Cash Per Share	0.20
Equity (Book Value)	-15.16M
Book Value Per Share	-0.32
Working Capital	12.60M

Cash Flow

In the last 12 months, operating cash flow was -29.26 million and capital expenditures -41,485, giving a free cash flow of -29.31 million.

Operating Cash Flow	-29.26M
Capital Expenditures	-41,485
Depreciation & Amortization	555,615
Net Borrowing	-129,384
Free Cash Flow	-29.31M
FCF Per Share	-0.63

Margins

Gross Margin	77.28%
Operating Margin	-1,779.00%
Pretax Margin	-1,492.08%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ETR:HPHA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.72%
Shareholder Yield	-0.72%
Earnings Yield	-31.80%
FCF Yield	-22.95%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 7, 2017. It was a forward split with a ratio of 1.0464082038.

Last Split Date	Nov 7, 2017
Split Type	Forward
Split Ratio	1.0464082038

Scores

Altman Z-Score	n/a
Piotroski F-Score	1